This is in agreement with a previous study conducted by Aktas et al., who depicted that apelin, the novel adipokine, was associated with the components of the metabolic syndrome (hyperlipidemia, obesity, and IR) in NAFLD patients [27]. The gene discussed is APLN; the disease is hyperlipidemia.